Secondary Hemophagocytic Lymphohistocytosis in COVID-19

  • Stephanie Lilia Pushpam Jetty Department of Pathology Father Muller Medical College Kankanady, Mangalore, Karnataka, India, 575002
  • Dotton Denis Noronha Department of Critical care & Internal medicine A.J. Hospital & Research Centre Kuntikana, Mangalore, Karnataka, India, 575004
  • Akshatha Nayak Department of Hematology A.J. Hospital & Research Centre Kuntikana, Mangalore, Karnataka, India, 575004
  • Altin Dsouza Department of Respiratory Therapy A.J. Hospital & Research Centre Kuntikana, Mangalore, Karnataka, India, 575004
DOI: https://doi.org/10.21276/apalm.3030
Keywords: Hemophagocytic lymphohistiocytosis, COVID-19, Severe Acute Respiratory Infection

Abstract

 We present case of a 53-year-old lady who is a known case of rheumatoid arthritis and hypertension in Karnataka, South India, who presented with Severe Acute Respiratory Infection (SARI) like symptoms  (fever, cough and breathlessness) due to COVID-19. During the course of treatment further investigations revealed evidence of Hemophagocytic Lymphohistocytosis (HLH). This case emphasizes the need for a thorough workup to identify the etiology of HLH as it may unmask a treatable entity in a COVID-19 patient.

References

Atteritano, M., David, A., Bagnato, G., Beninati, C., Frisina, A., Iaria, C. & Cascio, A. (2012) Haemophagocytic syndrome in rheumatic patients. A systematic review. European Review for Medical and Pharmacological Sciences, 16, 1414– 24.

Janka, G.E. & Lehmberg, K. (2014) Hemophagocytic syndromes ‐ An update. Blood Reviews, 28, 135– 142.

Ramos‐Casals, M., Brito‐Zerón, P., López‐Guillermo, A., Khamashta, M.A. & Bosch, X. (2014) Adult haemophagocytic syndrome. Lancet, 383, 1503– 16.

Kasahara, Y., Yachie, A., Takei, K., Kanegane, C., Okada, K., Ohta, K., Seki, H., Igarashi, N., Maruhashi, K., Katayama, K., Katoh, E., Terao, G., Sakiyama, Y. & Koizumi, S. (2001) Differential cellular targets of Epstein‐Barr virus (EBV) infection between acute EBV‐associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood, 98, 1882– 1888.

Rouphael, N.G., Talati, N.J., Vaughan, C., Cunningham, K., Moreira, R. & Gould, C. (2007) Infections associated with haemophagocytic syndrome. The Lancet. Infectious diseases, 7, 814– 822.

George, M.R. (2014) Hemophagocytic lymphohistiocytosis: review of etiologies and management. Journal of Blood Medicine, 5, 69– 86.

Atteritano, M., David, A., Bagnato, G., Beninati, C., Frisina, A., Iaria, C. & Cascio, A. (2012) Haemophagocytic syndrome in rheumatic patients. A systematic review. European Review for Medical and Pharmacological Sciences, 16, 1414– 24.

Zhang, M., Behrens, E.M., Atkinson, T.P., Shakoory, B., Grom, A.A. & Cron, R.Q. (2014b) Genetic defects in cytolysis in macrophage activation syndrome. Current Rheumatology Reports, 16, 439– 446.

Grom, A., Villanueva, J., Lee, S., Goldmuntz, E., Passo, M. & Filipovich, A.H. (2003) Natural killer cell dysfunction in patients with systemic‐onset rheumatoid arthritis and macrophage activation syndrome. Journal of Pediatrics, 29, 2– 296.

Ramanan, A.V. & Schneider, R. (2003) Macrophage activation syndrome–what's in a name!. The Journal of Rheumatology, 30, 2513– 6.

Grom, A.A. (2004) Natural killer cell dysfunction: a common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis and Rheumatism, 50, 689– 98.

Bryceson, Y.T., Pende, D., Maul‐Pavicic, A., Gilmour, K.C., Ufheil, H., Vraetz, T., Chiang, S.C., Marcenaro, S., Meazza, R., Bondzio, I., Walshe, D., Janka, G., Lehmberg, K., Beutel, K., zur Stadt, U., Binder, N., Arico, M., Moretta, L., Henter, J.I. & Ehl, S. (2012) A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood, 119, 2754– 2763.

Avau, A., Put, K., Wouters, C.H. & Matthys, P. (2015) Cytokine balance and cytokine‐driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine & Growth Factor Reviews, 26, 35– 45.

Canna, S.W. & Goldbach‐Mansky, R. (2015) New monogenetic autoinflammatory diseases—a clinical overview. Seminars in Immunopathology, 37, 387– 394.

Published
2021-02-28
Issue
Vol 8 No 2 (2021)
Section
Case Report

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).